Real-World Findings Reinforce Encelto’s Role in MacTel Treatment - Poll - MDSpire

Real-World Findings Reinforce Encelto’s Role in MacTel Treatment

Roger A. Goldberg, MD, MBA, shared early postapproval experience with Encelto, including an evolving surgical technique, at Clinical Trials at the Summit.

  • By

  • Jim Gallagher, senior managing editor

  • June 1, 2026

  • 4 min

Share

Original Source(s)

Real-World Findings Reinforce Encelto’s Role in MacTel Treatment

  • by Jim Gallagher, senior managing editor

  • June 1, 2026

Related Content

Floaters May Signal Higher Risk Than Flashes

New study examines retinal detachment risk in primary care presentations

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

The Retina’s Lost Lipid Signal

High-resolution metabolomics identifies erucamide depletion in retinal degeneration and links restoration to neurovascular rescue

  • June 30, 2026

  • 2 min